In vitro effects of ivermectin and sulphadiazine on Toxoplasma gondii

Balkan Medical Journal

Volumn 30, Issue 1, 2013, Pages 19-22

  Bilgin, Melek ^a   Yildirim, Tuba ^b   Hökelek, Murat ^c  

^a Samsun Education and Research Hospital   (Turkey)

^b AMASYA UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hep 2; In vitro; Ivermectin; Sulphadiazine; Toxoplasma gondii

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOGLOBULIN G ANTIBODY; IVERMECTIN; SULFADIAZINE;

ANIMAL TISSUE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SCREENING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LARYNX SQUAMOUS CELL CARCINOMA; MICROBIAL GROWTH; MOUSE; NONHUMAN; OPTICAL DENSITY; QUANTITATIVE ANALYSIS; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 84876004960     PISSN: 21463123     EISSN: 21463131     Source Type: Journal    
DOI: 10.5152/balkanmedj.2012.098     Document Type: Article

References (10)

1. Montaya JG, Liesenfeld O. Toxoplasmosis. The Lancet 2004;363:1965-76. [CrossRef]
2. th ed. Philadelphia:Elsevier Press;2008. p.3170-92.
3. Wilson M, Jones LJ, McAuley LB. Toxoplasma. In: Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of Clinical Microbiology. 9th ed. Washington:ASM Press;2005. p.2070-81.
4. Petersen E. Toxoplasmosis. Seminars in Fetal & Neonatal Medicine 2007;12:214-23. [CrossRef]
5. Merli A, Canessa A, Melioli G. Enzyme immunoassay for evaluation of Toxoplasma gondii growth in tissue culture. J Clin Microbiol 1985;21:88-91.
6. Derouin F, Chastang C. Enzyme Immunoassay to assess effect of antimicrobial agents on Toxoplasma gondii in tissue cultures. Antimicrob Agents Chemother 1988;32:303-7. [CrossRef]
7. Diab MR, El-Bahy MM. Toxoplasma gondii:Virulence of tachyzoites in serum free media at different temperatures. Exp Parasitol 2008;118:75-9. [CrossRef]
8. Meneceuri P, Bouldouyre MA, Aubert D, Villena I, Menotti J, Sauvage V, et al. Toxoplasma gondii:In vitro susceptibility of various genotypic strains to pyrimethamine, sulphadiazine and atovaquone. Antimicrob Agents Chemother 2008;52:1269-77. [CrossRef]
9. Derouin F, Chastang C. In vitro effects of folate inhibitors on Toxoplasma gondii. Antimicrob Agents Chemother 1989;33:1753-9. [CrossRef]
10. Guzzo CA, Furtek CI, Chen C, Tipping R, Clineschmidt CM, Sciberras DG, et al. Safety, tolerability, pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects. J Clin Pharmacol 2002;42:1122-33. [CrossRef]